'Pediatric use' presentation slideshows

The Overactive Bladder

The Overactive Bladder. Raji Gill, D.O., M.Sc. Clinical Assistant Professor of Surgery Division of Urology Tulsa Regional Medical Center & Cancer Treatment Centers of America. 2002 ICS Terminology: Overactive Bladder. OAB defined based on symptoms

1.29k views • 31 slides

One Year Post Exclusivity Adverse Event Review: Topotecan Pediatric Subcommittee of the Anti-infective Drugs Advisory C

One Year Post Exclusivity Adverse Event Review: Topotecan Pediatric Subcommittee of the Anti-infective Drugs Advisory Committee Meeting June 9, 2004. Susan McCune, MD, MA Ed Medical Officer Division of Pediatric Drug Development Center for Drug Evaluation and Research

395 views • 22 slides

Gardasil

352 views • 16 slides

One Year Post-Exclusivity Adverse Event Review: Ertapenem Pediatric Advisory Committee Meeting November 16, 2006

One Year Post-Exclusivity Adverse Event Review: Ertapenem Pediatric Advisory Committee Meeting November 16, 2006. Alan M. Shapiro, MD, PhD, FAAP Medical Officer Pediatrics and Maternal Health Staff Office of New Drugs Center for Drug Evaluation and Research Food and Drug Administration.

367 views • 9 slides